Terms: = Breast cancer AND B2M, P61769, 567, ENSG00000166710 AND Staging
7 results:
1. MIF as a potential diagnostic and prognostic biomarker for triple-negative breast cancer that correlates with the polarization of M2 macrophages.
Chen M; Liu H; Hong B; Xiao Y; Qian Y
FASEB J; 2024 May; 38(10):e23696. PubMed ID: 38787620
[TBL] [Abstract] [Full Text] [Related]
2. Imaging tests in staging and surveillance of non-metastatic breast cancer: changes in routine clinical practice and cost implications.
De Placido S; De Angelis C; Giuliano M; Pizzi C; Ruocco R; Perrone V; Bruzzese D; Tommasielli G; De Laurentiis M; Cammarota S; Arpino G; Arpino G
Br J Cancer; 2017 Mar; 116(6):821-827. PubMed ID: 28170371
[TBL] [Abstract] [Full Text] [Related]
3. ESR1, ERBB2, and Ki67 mRNA expression predicts stage and grade of non-muscle-invasive bladder carcinoma (NMIBC).
Breyer J; Wirtz RM; Laible M; Schlombs K; Erben P; Kriegmair MC; Stoehr R; Eidt S; Denzinger S; Burger M; Hartmann A; Otto W
Virchows Arch; 2016 Nov; 469(5):547-552. PubMed ID: 27514658
[TBL] [Abstract] [Full Text] [Related]
4. Adjuvant treatments of breast cancer increase the risk of depressive disorders: A population-based study.
Chang CH; Chen SJ; Liu CY
J Affect Disord; 2015 Aug; 182():44-9. PubMed ID: 25973782
[TBL] [Abstract] [Full Text] [Related]
5. Cost effectiveness of positron emission tomography in Canada.
Sloka JS; Hollett PD
Med Sci Monit; 2005 Oct; 11(10):PH1-6. PubMed ID: 16192911
[TBL] [Abstract] [Full Text] [Related]
6. Predicting response to adjuvant and radiation therapy in patients with early stage breast carcinoma.
Burke HB; Hoang A; Iglehart JD; Marks JR
Cancer; 1998 Mar; 82(5):874-7. PubMed ID: 9486576
[TBL] [Abstract] [Full Text] [Related]
7. Clinical value of carcinoembryonic antigen: diagnosis, prognosis, and follow-up of patients with cancer.
Beatty JD; Romero C; Brown PW; Lawrence W; Terz JJ
Arch Surg; 1979 May; 114(5):563-7. PubMed ID: 444049
[TBL] [Abstract] [Full Text] [Related]